Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Chicken Egg Yolk Antibodies (IgYs) block the binding of multiple SARS-CoV-2 spike protein variants to human ACE2.

International immunopharmacology - 1 Jan 2021

Wei Shuangshi, Duan Shengbao, Liu Xiaomei, Wang Hongmei, Ding Shaohua, Chen Yezhou, Xie Jinsong, Tian Jingjing, Yu Nong, Ge Pingju, Zhang Xinglin, Chen Xiaohong, Li Yong, Meng Qinglin

Abstract excerpt

The SARS-CoV-2 virus is still spreading worldwide, and there is an urgent need to effectively prevent and control this pandemic. This study evaluated the potential efficacy of Egg Yolk Antibodies (IgY) as a neutralizing agent against the SARS-CoV-2. We investigated the neutralizing effect of anti-spike-S1 IgYs on the SARS-CoV-2 pseudovirus, as well as its inhibitory effect on the binding of the coronavirus spike...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin-Converting Enzyme 2
Share to Antibodies, Neutralizing

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to COVID-19

Share to Egg Yolk

Share to Immunoglobulins

Share to Pandemics

Share to SARS-CoV-2

Share to Spike Glycoprotein, Coronavirus

Source

Open in PubMed Open full text

Identifiers

PMID: 33191178
DOI: 10.1016/j.intimp.2020.107172
PMCID: PMC7608017

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 10 closest

Chicken Egg Yolk Antibodies (IgYs) block the binding of multiple SARS-CoV-2 spike protein variants to human ACE2.PMID 33191178Read ↗

Edible formulations of chicken egg derived IgY antibodies neutralize SarsCoV2 Omicron RBD binding to human ACE2Semantic proximity Read ↗

Preparation of ingestible antibodies to neutralize the binding of SarsCoV2 RBD (receptor binding domain) to human ACE2 ReceptorSemantic proximity Read ↗

Rapid development and mass production of SARS-CoV-2 neutralizing Chicken egg yolk antibodies with protective efficacy in hamstersSemantic proximity Read ↗

Norwegian Platform for Production of Antiviral Chicken Egg Yolk Immunoglobulins for Viral Pandemics PreparednessSemantic proximity Read ↗

Egg-derived anti-SARS-CoV-2 immunoglobulin Y (IgY) with broad variant activity as intranasal prophylaxis against COVID-19Semantic proximity Read ↗

Spike protein binding prediction with neutralizing antibodies of SARS-CoV-2Semantic proximity Read ↗

Zebrafish studies on the vaccine candidate to COVID-19, the Spike protein: Production of antibody and adverse reactionSemantic proximity Read ↗

Egg Yolk Antibodies Elicited by a Novel Multi-Epitope Recombinant Adenovirus Vaccine Against Genotype G2b PEDV Spike Protein Reduce Mortality and Viral Shedding in Passively Immunized Piglets.Semantic proximity Read ↗

GB-2 blocking the interaction between ACE2 and wild type and mutation of spike protein of SARS-CoV-2.Semantic proximity Read ↗

In Silico and In Vitro Evaluation of the Molecular Mimicry of the SARS-CoV-2 Spike Protein by Common Short Constituent Sequences (cSCSs) in the Human Proteome: Toward Safer Epitope Design for Vaccine DevelopmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.